Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis

Oncogene volume 20, pages 4891–4898 (2001)Cite this article

Abstract

The ability to suppress wild type p53-independent apoptosis may play an important role in the oncogenicity of p53 mutant proteins. However, structural elements necessary for this activity are unknown. Furthermore, it is unclear whether this mutant p53 mediated inhibition is specific to the apoptotic pathway or a more general suppression of the cellular response to stress. We observed that an unmodified C-terminus was required for the suppression of apoptosis by the p53 135(Ala to Val) oncogenic p53 mutant. It was also required for the novel activity of G2 arrest suppression, the predominant response at low levels of genotoxic stress. These observations are consistent with a model whereby mutant p53 suppressive activity is not specific to the apoptotic pathway, but rather increases the threshold of genotoxic stress needed for a DNA damage response to occur. Furthermore, these observations indicate that it may be possible to selectively kill mutant p53 expressing cells based on the lower sensitivity of their growth arrest response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Agami R, Blandino G, Oren M, Shaul Y . 1999 Nature 399: 809–813

  • Almog N, Goldfinger N, Rotter V . 2000 Oncogene 19: 3395–3403

  • Almog N, Li R, Peled A, Schwartz D, Wolkowicz R, Goldfinger N, Pei H, Rotter V . 1997 Mol. Cell. Biol. 17: 713–722

  • Aloni-Grinstein R, Schwartz D, Rotter V . 1995 EMBO J. 14: 1392–1401

  • Anderson ME, Woelker B, Reed M, Wang P, Tegtmeyer P . 1997 Mol. Cell. Biol. 17: 6255–6264

  • Arai N, Nomura D, Yokota K, Wolf D, Brill E, Shohat O, Rotter V . 1986 Mol. Cell. Biol. 6: 3232–3239

  • Blagosklonny MV, Bishop PC, Robey R, Fojo T, Bates SE . 2000a Cancer Res. 60: 3425–3428

  • Blagosklonny MV, Robey R, Bates S, Fojo T . 2000b J. Clin. Invest. 105: 533–539

  • Blandino G, Levine AJ, Oren M . 1999 Oncogene 18: 477–485

  • Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B . 1999 Nature 401: 616–620

  • Chene P . 1998 J. Mol. Biol. 281: 205–209

  • Crook T, Vousden KH . 1992 EMBO J. 11: 3935–3940

  • Darzynkiewicz Z . 1994a Methods Cell Biol. 41: 427–541

  • Darzynkiewicz Z . 1994b Cell Biol. Lab. Handb. 1: 261–271

  • Davison TS, Vagner C, Kaghad M, Ayed A, Caput D, Arrowsmith CH . 1999 J. Biol. Chem. 274: 18709–18714

  • Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC, Pierotti MA . 1997 Oncogene 14: 2137–2147

  • Di Como CJ, Gaiddon C, Prives C . 1999 Mol. Cell. Biol. 19: 1438–1449

  • Dittmer D, Pati S, Zambetti G, Chu S, Teresky A, Moore M, Finlay C, Levine A . 1993 Nature Genet. 4: 42–46

  • Frazier MW, He X, Wang J, Gu Z, Cleveland JL, Zambetti GP . 1998 Mol. Cell. Biol. 18: 3735–3743

  • Goi K, Takagi M, Iwata S, Delia D, Asada M, Donghi R, Tsunematsu Y, Nakazawa S, Yamamoto H, Yokota J, Tamura K, Saeki Y, Utsunomiya J, Takahashi T, Ueda R, Ishioka C, Eguchi M, Kamata N, Mizutani S . 1997 Cancer Res. 57: 1895–1902

  • Gu W, Roeder RG . 1997 Cell 90: 595–606

  • Hsiao M, Low J, Dorn E, Ku D, Pattengale P, Yeargin J, Haas M . 1994 Am. J. Pathol. 145: 702–714

  • Hupp TR, Lane DP . 1994 Curr. Biol. 4: 865–875

  • Hupp TR, Meek DW, Midgley CA, Lane DP . 1992 Cell 71: 875–886

  • Hupp TR, Meek DW, Midgley CA, Lane DP . 1993 Nucleic Acids Res. 21: 3167–3174

  • Hupp TR, Sparks A, Lane DP . 1995 Cell 83: 237–245

  • Hussain SP, Harris CC . 1998 Cancer Res. 58: 4023–4037

  • Iwamoto KS, Mizuno T, Ito T, Tsuyama N, Kyoizumi S, Seyama T . 1996 Cancer Res. 56: 3862–3865

  • Kern SE, Pietenpol JA, Thiagalingam S, Seymor A, Kinzler KW, Vogelstein B . 1992 Science 256: 827–830

  • Ko JL, Prives C . 1996 Genes Dev. 10: 1054–1072

  • Lanyi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA, Deb S . 1998 Oncogene 16: 3169–3176

  • Lassus P, Bertrand C, Zugasti O, Chambon JP, Soussi T, Mathieu-Mahul D, Hibner U . 1999 Oncogene 18: 4699–4709

  • Lassus P, Ferlin M, Piette J, Hibner U . 1996 EMBO J. 15: 4566–4573

  • Lee YI, Lee S, Das GC, Park US, Park SM, Lee YI . 2000 Oncogene 19: 3717–3726

  • Levine JA . 1997 Cell 88: 323–331

  • Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M, Rotter V . 1998 Oncogene 16: 3269–3277

  • Lin J, Teresky AK, Levine AJ . 1995 Oncogene 10: 2387–2390

  • Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin WG . 2000 Nature Genet. 25: 47–54

  • Marston NJ, Ludwig RL, Vousden KH . 1998 Oncogene 16: 3132–3131

  • Michalovitz D, Halevy O, Oren M . 1990 Cell 62: 671–680

  • Milner J, Medcalf EA . 1991 Cell 65: 765–774

  • Mundt M, Hupp T, Fritsche M, Merkle C, Hansen S, Lane D, Groner B . 1997 Oncogene 15: 237–244

  • Murphy KL, Dennis AP, Rosen JM . 2000 FASEB J. 14: 2291–2302

  • Peled A, Zipori D, Rotter V . 1996 Cancer Res. 56: 2148–2156

  • Powell S, Defrank J, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, Friend S . 1995 Cancer Res. 55: 1643–1648

  • Schwartz D, Rotter V . 1998 Semin. Cancer Biol. 8: 325–336

  • Selivanova G, Kawasaki T, Ryabchenko L, Wiman KG . 1998 Semin. Cancer Biol. 8: 369–378

  • Shaulian E, Zauberman A, Ginsberg D, Oren M . 1992 Mol. Cell. Biol. 12: 5581–5592

  • Shaulsky G, Goldfinger N, Ben-Ze'ev A, Rotter V . 1990 Mol. Cell. Biol. 10: 6565–6577

  • Shaulsky G, Goldfinger N, Rotter V . 1991 Cancer Res. 51: 5232–5237

  • Sigal A, Rotter V . 2000 Cancer Res. 60: 6788–6793

  • Srivastava S, Wang S, Tong YO, Hao ZM, Chang E . 1993 Cancer Res. 53: 4452–4455

  • Strano S, Munarriz E, Rossi M, Cristofanelli B, Shaul Y, Castagnoli L, Levine AJ, Sacchi A, Cesareni G, Oren M, Blandino G . 2000 J. Biol. Chem. 275: 29503–29512

  • Unger T, Mietz JA, Scheffner M, Yee CL, Howley PM . 1993 Mol. Cell. Biol. 13: 5186–5194

  • Wang JY . 2000 Oncogene 19: 5643–5650

  • Wolf D, Harris N, Rotter V . 1984 Cell 38: 119

  • Wolkowicz R, Peled A, Elkind NB, Rotter V . 1995 Proc. Natl. Acad. Sci. USA 92: 6842–6846

  • Wolkowicz R, Peled A, Elkind NB, Rotter V . 1998 Cancer Detect. Prev. 22: 1–13

  • Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R, Kufe D . 1999 Nature 399: 814–817

  • Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ . 2000 Genes Dev. 14: 981–993

  • Zhou BB, Elledge SJ . 2000 Nature 408: 433–439

Download references

Acknowledgements

A Sigal wishes to thank Ayala Sharp and Eitan Ariel for lessons in flow cytometry. This work was supported in part by grants from the Israel-USA Binational Science Foundation (BSF) the DIP (Deutsch-Israelische Projektkooperation) and the Kadoori Foundation. V Rotter is the incumbent of the Norman and Helen Asher Professorial Chair in Cancer Research at the Weizmann Institute.

Author information

Authors and Affiliations

  1. Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel

    Alex Sigal, Devorah Matas, Nava Almog, Naomi Goldfinger & Varda Rotter

Authors
  1. Alex Sigal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Devorah Matas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nava Almog
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naomi Goldfinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Varda Rotter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Varda Rotter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sigal, A., Matas, D., Almog, N. et al. The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis. Oncogene 20, 4891–4898 (2001). https://doi.org/10.1038/sj.onc.1204724

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204724

Keywords

This article is cited by

Search

Advanced search

Quick links